Ellicott City, MD, United States of America

Manoj K Mishra

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Brain Tumor Treatment by Manoj K Mishra

Introduction

Manoj K Mishra is an accomplished inventor based in Ellicott City, MD (US). He has made significant contributions to the field of medical science, particularly in the treatment of brain tumors. His innovative approach focuses on the use of dendrimers for targeted drug delivery.

Latest Patents

Manoj K Mishra holds a patent for "Selective dendrimer delivery to brain tumors." This invention involves a composition comprising poly(amidoamine) (PAMAM) hydroxyl-terminated dendrimers that are covalently linked to therapeutic, prophylactic, or diagnostic agents. These dendrimers are designed to treat or alleviate symptoms of brain tumors effectively. The G6 dendrimers, in particular, have shown unexpectedly high uptake into the brain, allowing for selective delivery through the blood-brain barrier (BBB) of various agents. This innovative method provides a means for simultaneous delivery of different classes of compounds, enhancing treatment efficacy.

Career Highlights

Manoj K Mishra is associated with The Johns Hopkins University, where he continues to advance research in the field of medical innovations. His work has garnered attention for its potential to improve treatment outcomes for patients suffering from brain tumors.

Collaborations

Some of his notable coworkers include Kannan Rangaramanujam and Betty M Tyler, who have contributed to the research and development of his innovative projects.

Conclusion

Manoj K Mishra's work exemplifies the intersection of innovation and medical science, particularly in the realm of brain tumor treatment. His patented dendrimer technology represents a significant advancement in targeted drug delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…